ChromaCode: Patrick Balthrop, Kevin O’Boyle

Patrick Balthrop and Kevin O’Boyle have joined the board of directors of molecular diagnostics developer ChromaCode. Balthrop is the former CEO and president of Luminex. He is also chairman of the board at Agendia; chairman of Discovery Life Sciences; and a founding principal of Apalachee Ventures. O’Boyle was most recently chairman of the board at GenMark Diagnostics, which was acquired by Roche in March. He is also currently a member of the board of directors at Nevro and Sientra.